Memorial Sloan Kettering Cancer Center

https://www.mskcc.org/healthcare-professionals

Refer a Patient to MSKCC: mskcc.org/refer

 

SABCS 2021 Updates on Neratinib + Fulvestrant + Trastuzumab for HR+/HER2-Mutant MBC, and Neratinib + Trastuzumab for HER2-Mutant mTNBC: SUMMIT Trial Results

277 views
December 20, 2021
Comments 0
Login to view comments. Click here to Login